Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, Without Compromising the Quality of Colonoscopy? An International Multi-centre Randomized Controlled Trial.

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorChinese University of Hong Kong

About this trial

The goal of this study is to assess the clinical and cost-effectiveness of the AI bowel preparation evaluation system in reducing the consumption volume of the standard high-volume PEG regimen before colonoscopy among the older population.

Researchers will compare bowel preparation adequacy and other colonoscopy quality matrices, and patient satisfaction between patients using the AI system and those using Standard Practice.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

individual aged 65 years or above

undergoing colonoscopy for any indication

requiring a standard high-volume PEG regimen for bowel preparation

having a smartphone themselves or their caregivers (including ward nurses) having one will be recruited.

Disqualifiers

allergy to PEG,

suspected or diagnosed gastrointestinal obstruction or perforation,

suspected or diagnosed ileus

suspected or diagnosed gastric retention

Trial design

Design model

Parallel

Treatments tested in this trial

  • AI

    Device

    Each photo will be uploaded and analyzed by AI to predict the adequacy of their bowel preparation with immediate results of "pass" or "not pass," indicating if their bowel preparation is adequate or inadequate. If the result is "pass," patients will stop consuming the remaining PEG solution. If the result is "not pass," patients will be advised to gently rub their lower abdomen in a clockwise direction or walk around and continue consuming the remaining PEG until the AI evaluation gives a "pass" result or until the full dose of 3 L PEG have been consumed. If the patient's rectal effluent deems IBP after consumption of the full dose of 3 L of PEG, an additional 1 L or more of PEG will be administered as a remedial dose at the discretion of the physician-in-charge.

Treatment groups

1,824 Participants
are divided into 2 treatment groups
Group A: Standard practice group (SP group)No intervention 0 interventions
Group B: AI bowel preparation (AI group)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Volume of PEG consumed

The primary outcome of this study is the volume of PEG consumed before colonoscopy between the AI and SP groups.

Time frame
Baseline (before colonoscopy procedure)

Secondary outcomes

1

BBPS score

BBPS during procedure

Time frame
during colonoscopy
2

Bowel preparation adequacy rate

How adequate the bowel preparation rate

Time frame
during colonoscopy
3

Caecal intubation rate

Rather it was successful or not caecum is reached during colonscopy

Time frame
during colonoscopy
4

Adenoma detection rate

The chance of discovering adenoma

Time frame
during colonoscopy

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: